Dover Other Non-Current Liabilities decreased by 2.8% to $469.38M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.1%, from $459.53M to $469.38M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -3.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $564.61M | $575.11M | $532.54M | $524.94M | $524.33M | $496.05M | $474.90M | $471.09M | $470.23M | $437.28M | $426.91M | $499.03M | $492.10M | $460.18M | $471.13M | $459.53M | $491.07M | $489.65M | $483.07M | $469.38M |
| QoQ Change | — | +1.9% | -7.4% | -1.4% | -0.1% | -5.4% | -4.3% | -0.8% | -0.2% | -7.0% | -2.4% | +16.9% | -1.4% | -6.5% | +2.4% | -2.5% | +6.9% | -0.3% | -1.3% | -2.8% |
| YoY Change | — | — | — | — | -7.1% | -13.7% | -10.8% | -10.3% | -10.3% | -11.8% | -10.1% | +5.9% | +4.7% | +5.2% | +10.4% | -7.9% | -0.2% | +6.4% | +2.5% | +2.1% |